Skip to content
10-K

Annual Report

Kite Pharma, Inc.

0001510580-17-000003

← back to feed
Filed
Feb 28, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Feb 24, 2017 50.19M sh
Capex FY 2016 · Dec 31, 2016 $20.15M
Capex FY 2016 · Dec 31, 2015 $26.57M
Capex FY 2016 · Dec 31, 2014 $2.1M
Operating Cash Flow FY 2016 · Dec 31, 2016 −$168.9M
Operating Cash Flow FY 2016 · Dec 31, 2015 −$19.03M
Operating Cash Flow FY 2016 · Dec 31, 2014 −$17.07M
Cash And Equivalents FY 2016 · Dec 31, 2016 $114.56M
Cash And Equivalents FY 2016 · Dec 31, 2015 $392.84M
Cash And Equivalents FY 2016 · Dec 31, 2014 $209.3M
Cash And Equivalents FY 2016 · Dec 31, 2013 $22.36M
Stockholders Equity FY 2016 · Dec 31, 2016 $427.97M
Stockholders Equity FY 2016 · Dec 31, 2015 $615.76M
Stockholders Equity FY 2016 · Dec 31, 2014 $362.59M
Stockholders Equity FY 2016 · Dec 31, 2013 $21.58M
Current Liabilities FY 2016 · Dec 31, 2016 $55.14M
Current Liabilities FY 2016 · Dec 31, 2015 $36.17M
Total Liabilities FY 2016 · Dec 31, 2016 $96.33M
Total Liabilities FY 2016 · Dec 31, 2015 $92.2M
Current Assets FY 2016 · Dec 31, 2016 $427.4M
Current Assets FY 2016 · Dec 31, 2015 $631.09M
Total Assets FY 2016 · Dec 31, 2016 $524.3M
Total Assets FY 2016 · Dec 31, 2015 $707.96M
Sga Expense FY 2016 · Dec 31, 2016 $97.42M
Sga Expense restated FY 2016 · Dec 31, 2015 $44.84M
Sga Expense FY 2016 · Dec 31, 2014 $13.57M
Rd Expense FY 2016 · Dec 31, 2016 $197.93M
Rd Expense FY 2016 · Dec 31, 2015 $76.37M
Rd Expense FY 2016 · Dec 31, 2014 $23.09M
Net Income FY 2016 · Dec 31, 2016 −$267.07M
Net Income FY 2016 · Dec 31, 2015 −$101.65M
Net Income FY 2016 · Dec 31, 2014 −$42.57M
Operating Income FY 2016 · Dec 31, 2016 −$85.8M
Operating Income FY 2016 · Dec 31, 2016 −$273.19M
Operating Income FY 2016 · Sep 30, 2016 −$75.15M
Operating Income FY 2016 · Jun 30, 2016 −$66.27M
Operating Income FY 2016 · Mar 31, 2016 −$45.97M
Operating Income restated FY 2016 · Dec 31, 2015 −$38.22M
Operating Income restated FY 2016 · Dec 31, 2015 −$103.95M
Operating Income restated FY 2016 · Sep 30, 2015 −$27.96M
Operating Income restated FY 2016 · Jun 30, 2015 −$22.15M
Operating Income restated FY 2016 · Mar 31, 2015 −$15.62M
Operating Income FY 2016 · Dec 31, 2014 −$36.66M
Revenue FY 2016 · Dec 31, 2016 $4.91M
Revenue FY 2016 · Dec 31, 2016 $22.17M
Revenue FY 2016 · Sep 30, 2016 $7.34M
Revenue FY 2016 · Jun 30, 2016 $4.8M
Revenue FY 2016 · Mar 31, 2016 $5.13M
Revenue FY 2016 · Dec 31, 2015 $4.89M
Revenue FY 2016 · Dec 31, 2015 $17.26M
Revenue FY 2016 · Sep 30, 2015 $5.09M
Revenue FY 2016 · Jun 30, 2015 $4.4M
Revenue FY 2016 · Mar 31, 2015 $2.88M
Revenue FY 2016 · Dec 31, 2014 $0